NCT02648009View on ClinicalTrials.gov

Metabolic Imaging of the Heart Using Hyperpolarized (13C) Pyruvate Injection

PHASE1RecruitingINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2025

Conditions
HypertensionHypertrophy
Interventions
DRUG

Hyperpolarized (13) Pyruvate Injection

MRI with Hyperpolarized Pyruvate (13) Injection

DRUG

Gadolinium

MRI with Gadolinium

Trial Locations (2)

M4N 3M5

RECRUITING

Sunnybrook Health Sciences Centre, Toronto

Unknown

NOT_YET_RECRUITING

St. Michael's Hospital, Toronto

All Listed Sponsors
lead

Sunnybrook Health Sciences Centre

OTHER